The Senores Pharma IPO received bids for 79.72 crore shares against 85.34 lakh shares on offer.Qualified institutional buyers subscribed 94.66 times, non-institutional investors subscribed 96.11 times, retail portion subscribed 89.23 times, and employee quota subscribed 19.92 times.The grey market premium (GMP) for Senores Pharma IPO is ₹230, suggesting a potential listing gain of around 59% over the issue price of ₹391.Senores Pharma shares are tentatively scheduled to list on BSE and NSE on December 30.